U.S., Oct. 30 -- ClinicalTrials.gov registry received information related to the study (NCT07903402) titled 'AGU Registry and NHS' on April 02.
Brief Summary: The Aspartylglucosaminuria (AGU) Registry and Natural History Study (AGU Registry) aims to gain a more comprehensive understanding of Aspartylglucosaminuria (AGU) disease through an in-depth understanding of the disease progression in global patient population and burden of the disease on the family and caretakers.
Study Start Date: Nov. 29, 2024
Study Type: OBSERVATIONAL
Condition:
Aspartylglucosaminuria
Aspartylglucosamidase (AGA) Deficiency
Recruitment Status: RECRUITING
Sponsor: Rare Trait Hope
Disclaimer: Curated by HT Syndication....